Stocks and Investing
Stocks and Investing
Tue, July 9, 2024
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
Elizabeth Anderson Maintained (XRAY) at Buy with Decreased Target to $27 on, Jul 9th, 2024
Elizabeth Anderson of Evercore ISI Group, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Buy with Decreased Target from $28 to $27 on, Jul 9th, 2024.
Elizabeth has made no other calls on XRAY in the last 4 months.
There are 5 other peers that have a rating on XRAY. Out of the 5 peers that are also analyzing XRAY, 3 agree with Elizabeth's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $30 on, Monday, May 6th, 2024
- Jason Bednar of "Piper Sandler" Reiterated at Hold with Decreased Target to $32 on, Friday, May 3rd, 2024
- Jeffrey Johnson of "Baird" Maintained at Hold with Decreased Target to $33 on, Friday, May 3rd, 2024
These are the ratings of the 2 analyists that currently disagree with Elizabeth
- Michael Petusky of "Barrington Research" Maintained at Buy and Held Target at $38 on, Monday, July 8th, 2024
- David Saxon of "Needham" Maintained at Strong Buy with Decreased Target to $36 on, Friday, May 3rd, 2024
Contributing Sources